MEK inhibitor, U0126, attenuates cisplatin-induced renal injury by decreasing inflammation and apoptosis
- 1 February 2005
- journal article
- Published by Elsevier in Kidney International
- Vol. 67 (2) , 458-466
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Salicylate reduces cisplatin nephrotoxicity by inhibition of tumor necrosis factor-αKidney International, 2004
- Molecular Mechanisms of Renal Tissue Repair in Survival from Acute Renal Tubule Necrosis: Role of ERK1/2 PathwayToxicologic Pathology, 2003
- Cisplatin nephrotoxicitySeminars in Nephrology, 2003
- Possible Involvement of Oxidative Stress in Cisplatin-Induced Apoptosis in LLC-PK1 CellsJournal of Toxicology and Environmental Health, Part A, 2003
- Direct involvement of the receptor-mediated apoptotic pathways in cisplatin-induced renal tubular cell deathKidney International, 2003
- Cisplatin-Induced Renal Cell Apoptosis: Caspase 3-Dependent and -Independent PathwaysThe Journal of Pharmacology and Experimental Therapeutics, 2002
- Interleukin-10 inhibits ischemic and cisplatin-induced acute renal injuryKidney International, 2001
- Role and regulation of activation of caspases in cisplatin-induced injury to renal tubular epithelial cellsKidney International, 2001
- Effect of Extracellular Signal-regulated Kinase on p53 Accumulation in Response to CisplatinJournal of Biological Chemistry, 2000
- Uptake and metabolism of cisplatin by rat kidneyKidney International, 1984